Other studies have suggested that obesity can promote PanIN development through sustained inflammation, dysregulated metabolism, or aberrant islet β-cell expression of peptide hormone cholecystokinin (Cck) [43, 51–53]. The gene discussed is CCK; the disease is obesity due to melanocortin 4 receptor deficiency.